Skip to main content
SpringerLink
Log in

Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity

  • Chapter
  • First Online:
Coronavirus Therapeutics – Volume II

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1353))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Albillos A, Lario M, Álvarez-Mon M (2014) Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol 61(6):1385–1396

    CAS  PubMed  Google Scholar 

  • Anderson JA, Weitz JI (2011) Hypercoagulable states. Crit Care Clin 27(4):933–vii

    PubMed  Google Scholar 

  • Apicella M, Campopiano MC, Mantuano M et al (2020) COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol 8:782–792

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bassendine MF, Bridge SH, McCaughan GW, Gorrell MD (2020) COVID-19 and comorbidities: a role for dipeptidyl peptidase 4 (DPP4) in disease severity? [published online ahead of print, 2020 May 11]. J Diabetes. https://doi.org/10.1111/1753-0407.13052

  • Bokov P, Delclaux C (2019) The impact of obesity on respiratory function. Rev Mal Respir 36(9):1057–1063

    CAS  PubMed  Google Scholar 

  • Buscemi S, Giordano C (2017) Physical activity and cardiovascular prevention: is healthy urban living a possible reality or utopia? Eur J Intern Med 40:8–15

    PubMed  Google Scholar 

  • Buscemi S, Buscemi C, Batsis JA (2020) There is a relationship between obesity and COVID-19 but more information is needed. [published online ahead of print, 2020 May 12]. Obesity (Silver Spring). https://doi.org/10.1002/oby.22883

  • Busetto L, Bettini S, Fabris R et al (2020) Obesity and COVID-19: an Italian snapshot. [published online ahead of print, 2020 May 28]. Obesity (Silver Spring). https://doi.org/10.1002/oby.22918

  • Cai Q, Chen F, Wang T et al (2020) Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabet Care 43(7):1392–1398

    CAS  Google Scholar 

  • Chen C, Chen C, Yan JT, Zhou N, Zhao JP, Wang DW (2020a) Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi 48(0):E008

    Google Scholar 

  • Chen CF, Chien CH, Yang YP et al (2020b) Role of dipeptidyl peptidase 4 inhibitors in diabetic patients with coronavirus-19 infection. [published online ahead of print, 2020 Apr 27]. J Chin Med Assoc. https://doi.org/10.1097/JCMA.0000000000000338

  • Chen M, Wang B, Xu Y et al (2014) Diagnostic value of serum leptin and a promising novel diagnostic model for sepsis. Exp Ther Med 7(4):881–886

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chooi YC, Ding C, Magkos F (2019) The epidemiology of obesity. Metabolism 92:6–10

    CAS  PubMed  Google Scholar 

  • Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5(4):536–544

    Google Scholar 

  • Drummond GR, Vinh A, Guzik TJ, Sobey CG (2019) Immune mechanisms of hypertension. Nat Rev Immunol 19(8):517–532

    CAS  PubMed  Google Scholar 

  • Fadini GP, Morieri ML, Longato E et al (2020) Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study. [published online ahead of print, 2020 May 28]. Diabetes Obes Metab. https://doi.org/10.1111/dom.14097

  • Fosbøl EL, Butt JH, Østergaard L et al (2020) Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality. [published online ahead of print, 2020 Jun 19]. JAMA:e2011301

    Google Scholar 

  • Gao F, Zheng KI, Wang XB et al (2020) Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients. [published online ahead of print, 2020 May 21]. J Gastroenterol Hepatol. https://doi.org/10.1111/jgh.15112

  • Goyal P, Choi JJ, Pinheiro LC et al (2020) Clinical characteristics of Covid-19 in New York City. N Engl J Med 382(24):2372–2374

    PubMed  Google Scholar 

  • Grasselli G, Zangrillo A, Zanella A et al (2020) Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 323(16):1574–1581

    CAS  PubMed  PubMed Central  Google Scholar 

  • Guan WJ, Ni ZY, Hu Y et al (2020a) Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720

    CAS  PubMed  Google Scholar 

  • Guan WJ, Liang WH, Zhao Y et al (2020b) Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 55(5):2000547

    CAS  PubMed  PubMed Central  Google Scholar 

  • Guo W, Li M, Dong Y et al (2020) Diabetes is a risk factor for the progression and prognosis of COVID-19. [published online ahead of print, 2020 Mar 31]. Diabetes Metab Res Rev:e3319

    Google Scholar 

  • Hamming I, van Goor H, Turner AJ et al (2008) Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats. Exp Physiol 93:631–638

    CAS  PubMed  Google Scholar 

  • Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271–280.e8

    PubMed  PubMed Central  Google Scholar 

  • http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioContenutiNuovoCoronavirus.jsp?lingua=italiano&id=5338&area=nuovoCoronavirus&menu=vuoto. Last accessed 12 June 2020

  • https://github.com/CSSEGISandData/COVID-19/blob/master/csse_covid_19_data/csse_covid_19_daily_reports_us/05-26-2020.csv. Last accessed 7 June 2020

  • https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician. Last accessed 15 June 2020

  • https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_16-aprile-2020.pdf. Last accessed 7 June 2020

  • https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_21_maggio.pdf. Last accessed 24 May 2020

  • https://www.rand.org/content/dam/rand/pubs/tools/TL200/TL221/RAND_TL221.pdf. Last accessed 24 May 2020

  • https://www.merriam-webster.com/dictionary/risk%20factor

  • Huttunen R, Syrjänen J (2010) Obesity and the outcome of infection. Lancet Infect Dis 10(7):442–443

    PubMed  Google Scholar 

  • Imai Y, Kuba K, Ohto-Nakanishi T et al (2010) Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ J 74(3):405–410. https://doi.org/10.1253/circj.cj-10-0045

    Article  CAS  PubMed  Google Scholar 

  • Kim J, Nam J (2020) Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection. [published online ahead of print, 2020 May 22]. Int J Obes:1–2

    Google Scholar 

  • Klang E, Kassim G, Soffer S, Freeman R, Levin MA, Reich DL (2020) Morbid obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50. [published online ahead of print, 2020 May 23]. Obesity (Silver Spring). https://doi.org/10.1002/oby.22913

  • Klemann C, Wagner L, Stephan M, von Horsten S (2016) Cut to the chase: a review of CD26/dipeptidyl peptidase-4’s (DPP4) entanglement in the immune system. Clin Exp Immunol 185:1–21

    CAS  PubMed  PubMed Central  Google Scholar 

  • Knapp S (2013) Diabetes and infection: is there a link? A mini-review. Gerontology 59(2):99–104

    CAS  PubMed  Google Scholar 

  • Koivula I, Sten M, Mäkelä PH (1994) Risk factors for pneumonia in the elderly. Am J Med 96(4):313–320

    CAS  PubMed  Google Scholar 

  • Kreutz R, Algharably EAE, Azizi M et al (2020) Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. [published online ahead of print, 2020 Apr 15]. Cardiovasc Res:cvaa097

    Google Scholar 

  • Li B, Yang J, Zhao F et al (2020a) Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 109(5):531–538

    CAS  PubMed  Google Scholar 

  • Li SR, Tang ZJ, Li ZH, Liu X (2020b) Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV. Eur J Clin Microbiol Infect Dis 39(6):1021–1026

    CAS  PubMed  PubMed Central  Google Scholar 

  • Li W, Moore MJ, Vasilieva N et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lighter J, Phillips M, Hochman S et al (2020) Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. [published online ahead of print, 2020 Apr 9]. Clin Infect Dis:ciaa415

    Google Scholar 

  • Lippi G, Wong J, Henry BM (2020) Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med 130(4):304–309

    PubMed  Google Scholar 

  • Malavazos AE, Corsi Romanelli MM, Bandera F, Iacobellis G (2020) Targeting the adipose tissue in COVID-19. Obesity (Silver Spring) 28(7):1178–1179

    CAS  Google Scholar 

  • McMichael TM, Currie DW, Clark S et al (2020) Epidemiology of Covid-19 in a long-term care facility in King County, Washington. N Engl J Med 382(21):2005–2011

    CAS  PubMed  Google Scholar 

  • Moon AM, Webb GJ, Aloman C et al (2020) High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. [published online ahead of print, 2020 May 21]. J Hepatol S0168-8278(20):30305–30306

    Google Scholar 

  • Myers LC, Parodi SM, Escobar GJ, Liu VX (2020) Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA 323(21):2195–2198

    CAS  PubMed  PubMed Central  Google Scholar 

  • NCD Risk Factor Collaboration (NCD-RisC) (2017) Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 389(10064):37–55

    Google Scholar 

  • Papadopoulos S, Brennan L (2015) Correlates of weight stigma in adults with overweight and obesity: a systematic literature review. Obesity (Silver Spring) 23(9):1743–1760

    Google Scholar 

  • Pearson-Stuttard J, Blundell S, Harris T et al (2016) Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol 4(2):148–158

    PubMed  Google Scholar 

  • Pérez-Pérez A, Vilariño-García T, Fernández-Riejos P et al (2017) Role of leptin as a link between metabolism and the immune system. Cytokine Growth Factor Rev 35:71–84

    PubMed  Google Scholar 

  • Petta S, Di Marco V, Pipitone RM et al (2018) Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: genetic and metabolic risk factors in a general population. Liver Int 38(11):2060–2068

    CAS  PubMed  Google Scholar 

  • Pinheiro TA, Barcala-Jorge AS, Andrade JMO et al (2017) Obesity and malnutrition similarly alter the renin-angiotensin system and inflammation in mice and human adipose. J Nutr Biochem 48:74–82.7

    CAS  PubMed  Google Scholar 

  • Pitocco D, Tartaglione L, Viti L et al (2020) Lack of type 1 diabetes involvement in SARS-COV-2 population: only a particular coincidence? Diabetes Res Clin Pract 164:108220

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA (2020) Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression. J Renin-Angiotensin-Aldosterone Syst 21(2):1470320320926899

    CAS  PubMed  PubMed Central  Google Scholar 

  • Raj VS, Mou H, Smits SL et al (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495(7440):251–254

    CAS  PubMed  PubMed Central  Google Scholar 

  • Richardson S, Hirsch JS, Narasimhan M et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. [published online ahead of print, 2020 Apr 22] [published correction appears in doi: 10.1001/jama.2020.7681]. JAMA 323(20):2052–2059

    CAS  PubMed  PubMed Central  Google Scholar 

  • Saeedi P, Petersohn I, Salpea P et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 157:107843

    PubMed  Google Scholar 

  • Sattar N, McInnes IB, McMurray JJV (2020) Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. [published online ahead of print, 2020 Apr 22]. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.120.047659

  • Shao S, Xu Q, Yu X, Pan R, Chen Y (2020) Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions. Pharmacol Ther 209:107503

    CAS  PubMed  PubMed Central  Google Scholar 

  • Simonnet A, Chetboun M, Poissy J et al (2020) High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring) 28(7):1195–1199

    CAS  Google Scholar 

  • Singh S, Khan A (2020) Clinical characteristics and outcomes of COVID-19 among patients with pre-existing liver disease in United States: A multi-center research network study. [published online ahead of print, 2020 May 3]. Gastroenterology S0016-5085(20):30585-0

    Google Scholar 

  • Targher G, Mantovani A, Wang XB et al (2020a) Patients with diabetes are at higher risk for severe illness from COVID-19. [published online ahead of print, 2020 May 13]. Diabetes Metab S1262-3636(20):30075–30076

    Google Scholar 

  • Targher G, Mantovani A, Byrne CD et al (2020b) Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores. [published online ahead of print, 2020 May 15]. Gut. gutjnl-2020-321611

    Google Scholar 

  • Tian W, Jiang W, Yao J et al (2020) Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. [published online ahead of print, 2020 May 22]. J Med Virol. https://doi.org/10.1002/jmv.26050

  • Tiwari S, Ndisang JF (2014) The role of obesity in cardiomyopathy and nephropathy. Curr Pharm Des 20(9):1409–1417

    CAS  PubMed  Google Scholar 

  • Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD (2020) Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med 382(17):1653–1659

    CAS  PubMed  Google Scholar 

  • Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181:281–292.e6

    PubMed  PubMed Central  Google Scholar 

  • Wang B, Li R, Lu Z, Huang Y (2020a) Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY) 12(7):6049–6057

    CAS  Google Scholar 

  • Wang D, Hu B, Hu C et al (2020b) Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus–infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang L, He W, Yu X et al (2020c) Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J. Infect. 80(6):639–645

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Z, Du Z, Zhu F (2020d) Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract 164:108214

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ward ZJ, Bleich SN, Cradock AL et al (2019) Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med 381(25):2440–2450

    PubMed  Google Scholar 

  • Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. [published online ahead of print, 2020 Mar 13]. JAMA Intern Med:e200994

    Google Scholar 

  • Yang J, Zheng Y, Gou X et al (2020a) Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 94:91–95

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yang X, Yu Y, Xu J et al (2020b) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. [published correction appears in Lancet Respir Med. 2020 Apr;8(4):e26]. Lancet Respir Med 8(5):475–481

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yao Q, Wang P, Wang X et al (2020) A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients. Pol Arch Intern Med 130(5):390–399

    PubMed  Google Scholar 

  • Zhang P, Zhu L, Cai J et al (2020) Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 126(12):1671–1681

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zheng Z, Peng F, Xu B et al (2020) Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. [published online ahead of print, 2020 Apr 23]. J Infect S0163-4453(20):30234–30236

    Google Scholar 

  • Zhou F, Yu T, Du R et al (2020a) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet 395(10229):1054–1062

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhou YJ, Zheng KI, Wang XB et al (2020b) Metabolic associated fatty liver disease is associated with severity of COVID-19. [published online ahead of print, 2020 Jun 23]. Liver Int. https://doi.org/10.1111/liv.14575

  • Zhu L, She ZG, Cheng X et al (2020) Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab 31(6):1068–1077.e3

    PubMed  PubMed Central  Google Scholar 

Download references

Conflict of Interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Funding

This study received no funds.

This chapter does not contain either any studies with human participants or any studies with animals performed by any of the authors.

Author information

Authors and Affiliations

  1. Dipartimento di Promozione della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza (PROMISE), University of Palermo (Italy), Palermo, Italy

    Silvio Buscemi, Davide Corleo & Cristiana Randazzo

Authors
  1. Silvio Buscemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Davide Corleo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cristiana Randazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Silvio Buscemi .

Editor information

Editors and Affiliations

  1. President & CEO, NampEVA BioTherapeutics LLC, Dover, DE, USA

    Alexzander A. A. Asea

  2. Department of Medicine and Precision Therapeutics Proteogenomics Diagnostic Center Eleanor N. Dana Cancer Center, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

    Punit Kaur

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Buscemi, S., Corleo, D., Randazzo, C. (2021). Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity. In: Asea, A.A.A., Kaur, P. (eds) Coronavirus Therapeutics – Volume II. Advances in Experimental Medicine and Biology, vol 1353. Springer, Cham. https://doi.org/10.1007/978-3-030-85113-2_7

Download citation

Publish with us

Policies and ethics

Search

Navigation